paclitaxel has been researched along with Giant Cell Tumor of Bone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, XY; Lao, LF; Qiu, ML; Shen, HX; Xiao, WY; Zong, Z | 1 |
Ang, ES; Chim, SM; Feng, HT; Pavlos, NJ; Scaife, RM; Steer, JH; Xu, J; Zheng, MH | 1 |
2 other study(ies) available for paclitaxel and Giant Cell Tumor of Bone
Article | Year |
---|---|
Paclitaxel Induce Apoptosis of Giant Cells Tumor of Bone via TP53INP1 Signaling.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Bone Neoplasms; Carrier Proteins; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Computational Biology; Drug Evaluation, Preclinical; Gene Expression Regulation, Neoplastic; Giant Cell Tumor of Bone; Heat-Shock Proteins; Humans; Paclitaxel; Poly (ADP-Ribose) Polymerase-1; Signal Transduction; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2019 |
Paclitaxel inhibits osteoclast formation and bone resorption via influencing mitotic cell cycle arrest and RANKL-induced activation of NF-κB and ERK.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Bone Resorption; Cell Line; Cytoskeleton; Extracellular Signal-Regulated MAP Kinases; Giant Cell Tumor of Bone; Humans; M Phase Cell Cycle Checkpoints; Mice; Mice, Inbred C57BL; Mitosis; NF-kappa B; Osteoclasts; Osteolysis; Paclitaxel; RANK Ligand | 2012 |